Profiles of Drug Substances, Excipients, and Related Methodology

Erscheinungsjahr 2022
ISBN: 978-0-323-85482-5
Verlag: William Andrew Publishing

Buch, Englisch, 398 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Profiles of Drug Substances, Excipients, and Related Methodology, Volume 47 covers all aspects of drug development and formulation of drugs, meeting the information needs of the drug development community that are essential to all phases of pharmaceutical development. This updated release includes comprehensive profiles of five drug compounds: Vinpocetine; Loratadine; Ticagrelor; Lodenafil; Danazol. The volume also contains a chapter reviewing "Application of Chemometrics using direct Spectroscopic methods as a QC tool in Pharmaceutical Industry and their Validation.�

Zielgruppe

Pharmacists; Pharmaceutical, medicinal, and analytical chemists; Pharmacologists; physicians.

Autoren/Hrsg.

Al-Majed, Abdulrahman

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie
• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Naturwissenschaften Chemie Analytische Chemie

Inhaltsverzeichnis

1. Vinpocetine (A comprehensive profile) Nasr Y. Khalil, Ahmed H. Bakheit, Hamad M. Alkahtani, and Turki al-Muhanna2. Loratadine Najla AlMasoud, Ahmed H. Bakheit, Munif Farhan M. Alshammari, Hatem A. Abdel-Aziz, and Haitham AlRabiah3. Ticagrelor Mohamed Fawzy Kabil, Ahmed S. Abo Dena, and Ibrahim M. El-Sherbiny4. Lodenafil Yahya M. Alshehri, Abdulrahman A. Al-Majed, Mohamed W. Attwa, and Ahmed H. Bakheit5. Danazol Abdullah A. Al-Badr6. Application of chemometrics using direct spectroscopic methods as a QC tool in pharmaceutical industry and their validation Lestyo Wulandari, Rinaldi Idroes, Teuku Rizky Noviandy, and Gunawan Indrayanto

Über Autor(innen)

Al-Majed, Abdulrahman
Professor Abdulrahman AlMajed obtained a Bachelor of Pharmaceutical Sciences from College of Pharmacy, King Saud University, Riyadh, Saudi Arabia in 1990 and a Ph.D. in the field of Pharmaceutical analytical Chemistry from the University of Bradford, UK, in 1997. He also received a Bachelor of Legislation from College of Legislation, Imam Mohammed Bin Saud University, Riyadh, Saudi Arabia. He was appointed as assistance professor in Pharmaceutical Chemistry Department at College of Pharmacy, King Saud University in 1998. He was promoted to the rank of associated professor in 2003. He was a head of Pharmaceutical Chemistry Department (2005-2019) (2015-2017). Since 2009, he is full professor of Pharmaceutical Analytical Chemistry. He was assistance secretary of Scientific Council at King Saud University and he is presently a member of Scientific Council in Princess Nourah Bint Abdul Rahman University and in Jouf University, Saudi Arabia. He also a member of Medical and health Sciences Committee of Qualification Recognition in Ministry of Education and a member of Patent Lawsuits Committee in Saudi Arabia. He is a member of several scientific and social Committees. He participated in several national and international conferences and symposia. Prof. Almajed has taught courses in the field of Pharmaceutical Analysis at both the undergraduate and postgraduate levels at College of Pharmacy. He is recently appointed as the Editor-In-Chief of the book series Profiles of Drug Substances, Excipients, and Related Methodology. He published 10 chapters in the series. Dr. AlMajed published over 65 research papers in the field of Pharmaceutical Analysis. His research is focused on determination and validation of pharmaceutical compounds in dosage forms or/and in biological fluids by analytical techniques including: HPLC, electrophoresis, spectrophotometry, spectrofluorometry, voltammetry. His research also includes resolution and quantitation of the R-(-)- and S-(+)- enantiomers of pharmaceutical compounds in dosage forms or/and in biological fluids using chiral stationary phases.